Trade icad - ICADus CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Trading Conditions
| Spread | 0.0654 | ||||||||
|
Long position overnight fee
Long position overnight fee
Go to platform | -0.024068% | ||||||||
|
Short position overnight fee
Short position overnight fee
Go to platform | 0.001846% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 20% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
*Information provided by Capital.com
Key Stats
| Prev. Close* | 2.0873 |
| Open* | 2.0873 |
| 1-Year Change* | -64.92% |
| Day's Range* | 2.0073 - 2.1172 |
| 52 wk Range | 1.25-4.68 |
| Average Volume (10 days) | 231.80K |
| Average Volume (3 months) | 3.01M |
| Market Cap | 32.32M |
| P/E Ratio | -100.00K |
| Shares Outstanding | 25.45M |
| Revenue | 29.26M |
| EPS | -0.58 |
| Dividend (Yield %) | N/A |
| Beta | 1.26 |
| Next Earnings Date | Mar 28, 2023 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Feb 10, 2023 | 2.0373 | -0.0499 | -2.39% | 2.0872 | 2.1172 | 2.0073 |
| Feb 9, 2023 | 2.0873 | -0.1198 | -5.43% | 2.2071 | 2.2271 | 1.9973 |
| Feb 8, 2023 | 2.1871 | -0.1099 | -4.78% | 2.2970 | 2.3769 | 2.1372 |
| Feb 7, 2023 | 2.2770 | 0.0100 | 0.44% | 2.2670 | 2.3170 | 2.1372 |
| Feb 6, 2023 | 2.2770 | -0.0799 | -3.39% | 2.3569 | 2.3969 | 2.1372 |
| Feb 3, 2023 | 2.3669 | 0.0500 | 2.16% | 2.3169 | 2.3869 | 2.2970 |
| Feb 2, 2023 | 2.3969 | 0.1299 | 5.73% | 2.2670 | 2.4268 | 2.2570 |
| Feb 1, 2023 | 2.2770 | -0.0200 | -0.87% | 2.2970 | 2.3370 | 2.1971 |
| Jan 31, 2023 | 2.2870 | 0.0400 | 1.78% | 2.2470 | 2.3270 | 2.2171 |
| Jan 30, 2023 | 2.1871 | -0.0599 | -2.67% | 2.2470 | 2.2471 | 2.1372 |
| Jan 27, 2023 | 2.2371 | 0.0999 | 4.67% | 2.1372 | 2.2970 | 2.1372 |
| Jan 26, 2023 | 2.1472 | 0.0000 | 0.00% | 2.1472 | 2.1572 | 2.0772 |
| Jan 25, 2023 | 2.1572 | -0.0399 | -1.82% | 2.1971 | 2.1971 | 2.0872 |
| Jan 24, 2023 | 2.2271 | -0.0299 | -1.32% | 2.2570 | 2.2770 | 2.2071 |
| Jan 23, 2023 | 2.2570 | -0.0200 | -0.88% | 2.2770 | 2.2970 | 2.1971 |
| Jan 20, 2023 | 2.2970 | 0.0800 | 3.61% | 2.2170 | 2.3070 | 2.1671 |
| Jan 19, 2023 | 2.2371 | -0.0099 | -0.44% | 2.2470 | 2.2770 | 2.1771 |
| Jan 18, 2023 | 2.2171 | 0.0300 | 1.37% | 2.1871 | 2.2371 | 2.1472 |
| Jan 17, 2023 | 2.1871 | -0.0200 | -0.91% | 2.2071 | 2.2071 | 2.1571 |
| Jan 13, 2023 | 2.1672 | 0.0999 | 4.83% | 2.0673 | 2.2670 | 2.0073 |
icad Events
| Time (UTC) | Country | Event |
|---|---|---|
| No events scheduled | ||
- Annual
- Quarterly
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Total revenue | 33.638 | 29.698 | 31.34 | 25.621 | 28.102 |
| Revenue | 33.638 | 29.698 | 31.34 | 25.621 | 28.102 |
| Cost of Revenue, Total | 9.395 | 8.344 | 7.113 | 6.191 | 9.926 |
| Gross Profit | 24.243 | 21.354 | 24.227 | 19.43 | 18.176 |
| Total Operating Expense | 44.756 | 39.427 | 37.737 | 33.751 | 42.27 |
| Selling/General/Admin. Expenses, Total | 25.541 | 22.429 | 21.077 | 17.81 | 18.38 |
| Research & Development | 9.194 | 8.114 | 9.271 | 9.445 | 9.327 |
| Depreciation / Amortization | 0.24 | 0.199 | 0.276 | 0.305 | 0.452 |
| Unusual Expense (Income) | 0.386 | 0.341 | 0 | 4.185 | |
| Operating Income | -11.118 | -9.729 | -6.397 | -8.13 | -14.168 |
| Interest Income (Expense), Net Non-Operating | -0.126 | -7.843 | -7.111 | -0.845 | -0.106 |
| Net Income Before Taxes | -11.244 | -17.572 | -13.508 | -8.975 | -14.274 |
| Net Income After Taxes | -11.245 | -17.61 | -13.551 | -9.017 | 4.844 |
| Net Income Before Extra. Items | -11.245 | -17.61 | -13.551 | -9.017 | 4.844 |
| Net Income | -11.245 | -17.61 | -13.551 | -9.017 | -14.256 |
| Income Available to Common Excl. Extra. Items | -11.245 | -17.61 | -13.551 | -9.017 | 4.844 |
| Income Available to Common Incl. Extra. Items | -11.245 | -17.61 | -13.551 | -9.017 | -14.256 |
| Diluted Net Income | -11.245 | -17.61 | -13.551 | -9.017 | -14.256 |
| Diluted Weighted Average Shares | 24.778 | 22.14 | 18.378 | 16.685 | 16.343 |
| Diluted EPS Excluding Extraordinary Items | -0.45383 | -0.79539 | -0.73735 | -0.54043 | 0.2964 |
| Diluted Normalized EPS | -0.4437 | -0.78538 | -0.73735 | -0.54043 | 0.46284 |
| Total Extraordinary Items | -19.1 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Total revenue | 7.523 | 7.808 | 9.361 | 7.826 | 8.644 |
| Revenue | 7.523 | 7.808 | 9.361 | 7.826 | 8.644 |
| Cost of Revenue, Total | 2.211 | 2.104 | 2.649 | 2.288 | 2.355 |
| Gross Profit | 5.312 | 5.704 | 6.712 | 5.538 | 6.289 |
| Total Operating Expense | 11.045 | 11.956 | 11.542 | 11.083 | 10.177 |
| Selling/General/Admin. Expenses, Total | 6.496 | 7.341 | 6.544 | 6.081 | 5.575 |
| Research & Development | 2.275 | 2.449 | 2.285 | 2.268 | 2.192 |
| Depreciation / Amortization | 0.063 | 0.062 | 0.064 | 0.06 | 0.055 |
| Unusual Expense (Income) | 0 | 0 | 0.386 | 0 | |
| Operating Income | -3.522 | -4.148 | -2.181 | -3.257 | -1.533 |
| Interest Income (Expense), Net Non-Operating | -0.009 | 0.003 | 0.005 | -0.023 | -0.11 |
| Net Income Before Taxes | -3.544 | -4.145 | -2.176 | -3.28 | -1.643 |
| Net Income After Taxes | -3.545 | -4.146 | -2.176 | -3.28 | -1.643 |
| Net Income Before Extra. Items | -3.545 | -4.146 | -2.176 | -3.28 | -1.643 |
| Net Income | -3.545 | -4.146 | -2.176 | -3.28 | -1.643 |
| Income Available to Common Excl. Extra. Items | -3.544 | -4.146 | -2.176 | -3.28 | -1.643 |
| Income Available to Common Incl. Extra. Items | -3.544 | -4.146 | -2.176 | -3.28 | -1.643 |
| Diluted Net Income | -3.544 | -4.146 | -2.176 | -3.28 | -1.643 |
| Diluted Weighted Average Shares | 25.16 | 25.126 | 25.053 | 24.989 | 23.929 |
| Diluted EPS Excluding Extraordinary Items | -0.14086 | -0.16501 | -0.08686 | -0.13126 | -0.06866 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| Diluted Normalized EPS | -0.14086 | -0.16501 | -0.08686 | -0.11581 | -0.06866 |
| Other, Net | -0.013 | ||||
| Total Adjustments to Net Income | 0.001 |
- Annual
- Quarterly
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Total Current Assets | 50.306 | 42.302 | 29.196 | 21.22 | 21.209 |
| Cash and Short Term Investments | 34.282 | 27.186 | 15.313 | 12.185 | 9.387 |
| Cash & Equivalents | 34.282 | 27.186 | 15.313 | 12.185 | 9.387 |
| Total Receivables, Net | 10.786 | 10.508 | 9.833 | 6.422 | 8.599 |
| Accounts Receivable - Trade, Net | 10.786 | 10.508 | 9.833 | 6.422 | 8.599 |
| Total Inventory | 4.171 | 3.144 | 2.611 | 1.587 | 2.123 |
| Prepaid Expenses | 1.067 | 1.464 | 1.439 | 1.026 | 1.1 |
| Other Current Assets, Total | 0 | ||||
| Total Assets | 62.191 | 55.582 | 41.748 | 31.737 | 32.131 |
| Property/Plant/Equipment, Total - Net | 1.941 | 2.502 | 2.957 | 0.552 | 0.576 |
| Property/Plant/Equipment, Total - Gross | 9.047 | 9.28 | 9.467 | 6.766 | 6.465 |
| Accumulated Depreciation, Total | -7.106 | -6.778 | -6.51 | -6.214 | -5.889 |
| Goodwill, Net | 8.362 | 8.362 | 8.362 | 8.362 | 8.362 |
| Intangibles, Net | 0.683 | 0.889 | 1.183 | 1.55 | 1.931 |
| Other Long Term Assets, Total | 0.055 | 0.093 | 0.05 | 0.053 | 0.053 |
| Total Current Liabilities | 14.962 | 16.751 | 18.836 | 13.245 | 12.07 |
| Accounts Payable | 2.779 | 2.869 | 1.99 | 1.154 | 1.362 |
| Accrued Expenses | 6.531 | 7.765 | 7.336 | 4.968 | 4.399 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 0 | 0 | 4.262 | 1.866 | 0.829 |
| Other Current Liabilities, Total | 5.652 | 6.117 | 5.248 | 5.257 | 5.48 |
| Total Liabilities | 15.674 | 25.057 | 36.677 | 24.841 | 17.855 |
| Total Long Term Debt | 0 | 6.96 | 15.645 | 11.235 | 5.146 |
| Capital Lease Obligations | 0.011 | 0.027 | |||
| Deferred Income Tax | 0.005 | 0.004 | 0.003 | 0.003 | 0.014 |
| Other Liabilities, Total | 0.707 | 1.342 | 2.193 | 0.358 | 0.625 |
| Total Equity | 46.517 | 30.525 | 5.071 | 6.896 | 14.276 |
| Preferred Stock - Non Redeemable, Net | 0 | 0 | |||
| Common Stock | 0.253 | 0.236 | 0.196 | 0.171 | 0.167 |
| Additional Paid-In Capital | 300.859 | 273.639 | 230.615 | 218.914 | 217.389 |
| Retained Earnings (Accumulated Deficit) | -253.18 | -241.935 | -224.325 | -210.774 | -201.865 |
| Treasury Stock - Common | -1.415 | -1.415 | -1.415 | -1.415 | -1.415 |
| Total Liabilities & Shareholders’ Equity | 62.191 | 55.582 | 41.748 | 31.737 | 32.131 |
| Total Common Shares Outstanding | 25.1403 | 23.5086 | 19.3603 | 16.8807 | 16.5259 |
| Long Term Debt | 0 | 6.96 | 15.645 | 11.224 | 5.119 |
| Note Receivable - Long Term | 0.844 | 1.434 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Total Current Assets | 47.933 | 50.306 | 52.876 | 53.599 | 62.242 |
| Cash and Short Term Investments | 29.798 | 34.282 | 35.805 | 37.889 | 46.907 |
| Cash & Equivalents | 29.798 | 34.282 | 35.805 | 37.889 | 46.907 |
| Total Receivables, Net | 11.483 | 10.786 | 12.45 | 11.849 | 11.35 |
| Accounts Receivable - Trade, Net | 11.483 | 10.786 | 12.45 | 11.849 | 11.35 |
| Total Inventory | 4.736 | 4.171 | 3.29 | 2.861 | 2.498 |
| Prepaid Expenses | 1.916 | 1.067 | 1.331 | 1 | 1.487 |
| Total Assets | 58.845 | 62.191 | 65.737 | 66.561 | 75.494 |
| Property/Plant/Equipment, Total - Net | 1.806 | 1.941 | 2.101 | 2.291 | 2.495 |
| Property/Plant/Equipment, Total - Gross | 8.139 | 7.988 | 7.945 | 7.856 | 7.784 |
| Accumulated Depreciation, Total | -7.192 | -7.106 | -7.02 | -6.935 | -6.854 |
| Goodwill, Net | 8.362 | 8.362 | 8.362 | 8.362 | 8.362 |
| Intangibles, Net | 0.64 | 0.683 | 0.741 | 0.777 | 0.831 |
| Note Receivable - Long Term | 0.049 | 0.844 | 1.602 | 1.478 | 1.478 |
| Other Long Term Assets, Total | 0.055 | 0.055 | 0.055 | 0.054 | 0.086 |
| Total Current Liabilities | 14.461 | 14.962 | 14.96 | 14.46 | 14.143 |
| Accounts Payable | 2.681 | 2.779 | 2.651 | 1.039 | 1.251 |
| Accrued Expenses | 6.015 | 6.531 | 6.379 | 7.457 | 6.666 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 0 | 0 | 0.269 | ||
| Other Current Liabilities, Total | 5.765 | 5.652 | 5.93 | 5.964 | 5.957 |
| Total Liabilities | 15.092 | 15.674 | 15.916 | 15.534 | 22.13 |
| Total Long Term Debt | 0 | 0 | 0 | 0 | 6.703 |
| Long Term Debt | 0 | 0 | 0 | 6.703 | |
| Deferred Income Tax | 0.006 | 0.005 | 0.005 | 0.004 | 0.004 |
| Other Liabilities, Total | 0.625 | 0.707 | 0.951 | 1.07 | 1.28 |
| Total Equity | 43.753 | 46.517 | 49.821 | 51.027 | 53.364 |
| Common Stock | 0.253 | 0.253 | 0.253 | 0.251 | 0.251 |
| Additional Paid-In Capital | 301.64 | 300.859 | 300.017 | 299.049 | 298.106 |
| Retained Earnings (Accumulated Deficit) | -256.725 | -253.18 | -249.034 | -246.858 | -243.578 |
| Treasury Stock - Common | -1.415 | -1.415 | -1.415 | -1.415 | -1.415 |
| Total Liabilities & Shareholders’ Equity | 58.845 | 62.191 | 65.737 | 66.561 | 75.494 |
| Total Common Shares Outstanding | 25.1733 | 25.1403 | 25.102 | 25.0275 | 24.9576 |
| Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 |
- Annual
- Quarterly
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -11.245 | -17.61 | -13.551 | -9.017 | -14.256 |
| Cash From Operating Activities | -9.408 | -6.985 | -7.107 | -3.867 | -7.337 |
| Cash From Operating Activities | 0.327 | 0.268 | 0.297 | 0.325 | 0.995 |
| Amortization | 0.23 | 0.309 | 0.377 | 0.383 | 0.494 |
| Deferred Taxes | 0.001 | 0.001 | 0.001 | -0.012 | 0.008 |
| Non-Cash Items | 3.45 | 10.821 | 8.051 | 1.912 | 9.366 |
| Cash Taxes Paid | 0 | 0.038 | 0.043 | 0.051 | 0.06 |
| Cash Interest Paid | 0.172 | 0.272 | 0.643 | 0.294 | 0.079 |
| Changes in Working Capital | -2.171 | -0.774 | -2.282 | 2.542 | -3.944 |
| Cash From Investing Activities | -0.587 | -0.474 | -0.306 | -0.316 | 2.455 |
| Capital Expenditures | -0.587 | -0.474 | -0.306 | -0.316 | -0.395 |
| Other Investing Cash Flow Items, Total | 0 | 2.85 | |||
| Cash From Financing Activities | 17.091 | 19.332 | 10.541 | 6.981 | 5.684 |
| Financing Cash Flow Items | -0.059 | -0.267 | -0.196 | -0.18 | -0.315 |
| Issuance (Retirement) of Stock, Net | 24.513 | 19.28 | 10.753 | 0.204 | 0.079 |
| Issuance (Retirement) of Debt, Net | -7.363 | 0.319 | -0.016 | 6.957 | 5.92 |
| Net Change in Cash | 7.096 | 11.873 | 3.128 | 2.798 | 0.802 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -3.545 | -11.245 | -7.099 | -4.923 | -1.643 |
| Cash From Operating Activities | -4.449 | -9.408 | -7.861 | -5.577 | -3.563 |
| Cash From Operating Activities | 0.086 | 0.327 | 0.242 | 0.115 | 0.076 |
| Amortization | 0.053 | 0.23 | 0.176 | 0.157 | 0.058 |
| Deferred Taxes | 0.001 | 0 | 0 | 0 | |
| Non-Cash Items | 0.961 | 3.45 | 2.48 | 1.846 | 0.947 |
| Cash Taxes Paid | 0 | 0 | 0 | 0 | |
| Cash Interest Paid | 0.009 | 0.172 | 0.092 | 0.092 | 0.092 |
| Changes in Working Capital | -2.004 | -2.171 | -3.66 | -2.772 | -3.001 |
| Cash From Investing Activities | -0.161 | -0.587 | -0.45 | -0.336 | -0.262 |
| Capital Expenditures | -0.161 | -0.587 | -0.45 | -0.336 | -0.262 |
| Cash From Financing Activities | 0.126 | 17.091 | 16.93 | 16.616 | 23.546 |
| Financing Cash Flow Items | -0.059 | -0.059 | 0 | 0 | |
| Issuance (Retirement) of Stock, Net | 0.126 | 24.513 | 24.352 | 23.979 | 23.546 |
| Issuance (Retirement) of Debt, Net | -7.363 | -7.363 | -7.363 | 0 | |
| Net Change in Cash | -4.484 | 7.096 | 8.619 | 10.703 | 19.721 |
| Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
|---|---|---|---|---|---|---|
| Granahan Investment Management, Inc. | Investment Advisor | 11.1966 | 2849124 | 270454 | 2022-12-31 | LOW |
| Pura Vida Investments, LLC | Hedge Fund | 5.0192 | 1277214 | 168545 | 2023-03-10 | MED |
| Victory Capital Management Inc. | Investment Advisor/Hedge Fund | 4.99 | 1269785 | 67200 | 2022-12-31 | LOW |
| Sassine (Andy H) | Individual Investor | 4.8666 | 1238382 | 43500 | 2022-04-29 | LOW |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 4.1493 | 1055845 | 485 | 2022-12-31 | LOW |
| First Eagle Investment Management, L.L.C. | Investment Advisor/Hedge Fund | 2.8628 | 728484 | 179498 | 2022-12-31 | LOW |
| Essex Investment Management Company, LLC | Investment Advisor/Hedge Fund | 1.738 | 442261 | -21947 | 2022-12-31 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.4337 | 364813 | 545 | 2022-12-31 | LOW |
| Greenwood Capital Associates, LLC | Investment Advisor | 1.2951 | 329568 | 102369 | 2022-12-31 | MED |
| Portolan Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.2897 | 328175 | -83549 | 2022-12-31 | HIGH |
| Perritt Capital Management, Inc. | Investment Advisor | 1.0794 | 274666 | 102016 | 2022-12-31 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.8731 | 222163 | 3261 | 2022-12-31 | LOW |
| JP Morgan Asset Management | Investment Advisor | 0.8641 | 219878 | 0 | 2022-12-31 | LOW |
| ACT Capital Management, L.L.C. | Hedge Fund | 0.8056 | 205000 | 0 | 2022-09-30 | MED |
| Go (Jonathan) | Individual Investor | 0.7417 | 188725 | 6040 | 2022-09-12 | LOW |
| Two Sigma Investments, LP | Hedge Fund | 0.7265 | 184862 | -68362 | 2022-12-31 | HIGH |
| Dalton (Nathaniel) | Individual Investor | 0.7229 | 183947 | 6900 | 2022-04-29 | LOW |
| GWM Advisors LLC | Investment Advisor | 0.683 | 173801 | -463 | 2022-12-31 | MED |
| DWS Investments UK Limited | Investment Advisor | 0.683 | 173787 | 0 | 2022-12-31 | MED |
| Renaissance Technologies LLC | Hedge Fund | 0.59 | 150133 | -61557 | 2022-12-31 | HIGH |
Why choose Capital.com? Our numbers speak for themselves.
Capital.com Group500K+
Traders
92K+
Active clients monthly
$53M+
Monthly investing volume
$30M+
Withdrawn each month
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
Trade commission
0
- 1:1
Leverage
1:1
- 20
- 100
- 500
- 1000
- 10000
Investment
Trade size (Leverage x Investement):
Open
Close
Short Long
icad Company profile
About iCAD Inc
iCAD, Inc. is a global medical technology company providing cancer detection and therapy solutions. The Company operates through two segments: Cancer Detection (Detection) and Cancer Therapy (Therapy). The Detection segment consists of its image analysis and workflow products, a range of Artificial Intelligence (AI), Computer-Aided Detection (CAD) systems and workflow solutions for two-dimensional (2D) and three-dimensional (3D) mammography, Magnetic Resonance Imaging (MRI) and Computed Tomography (CT). The Therapy segment consists of its radiation therapy products and offers the Xoft System, which is an isotope-free cancer treatment platform technology. The Company sells its products through its direct sales organization, as well as through various original equipment manufacturer partners, distributors and resellers.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, iCAD Inc revenues increased 13% to $33.6M. Net loss decreased 36% to $11.2M. Revenues reflect Products increase of 12% to $21.2M, Service and supplies increase of 15% to $12.4M. Lower net loss reflects Loss on fair value of convertible debent decrease from $7.5M (expense) to $0K. Basic Earnings per Share excluding Extraordinary Items increased from -$0.80 to -$0.45.
Equity composition
Common Stock $.01 Par, 12/10, 85M auth., 54,383,747 issd., less 67,876 shs. in Treas. @ $950K. Insiders & Strategic holders own 20.72%. PO 12/84, 1.25M shares @ $5 by Whale Secs. Convertible Preferred Stock $.01 Par, 1M auth., 0 issd. *7/02, Co. merged with Intelligent Systems Software, Inc. 08/12, 1-For-5 Reverse stock split.
| Industry: | Advanced Medical Equipment & Technology (NEC) |
98 Spit Brook Rd Ste 100
03062-5737
Income Statement
- Annual
- Quarterly
News
Gold price predictions for next 5 years: Will gold continue rising amid banking fallout?
The yellow metal started 2023 with a bang, yet will it maintain the momentum and for how long?
17:55, 21 March 2023
Cardano price prediction: What is next for ADA?
Can ADA capitalise on a recent price boost?
15:44, 21 March 2023
Nvidia shows off work with AT&T, quantum computing firms at AI conference
Adds details from keynote
15:29, 21 March 2023
ECB tells banks to watch their cash amid turmoil
Adds Enria's comments in parliament
15:27, 21 March 2023
TotalEnergies sticks to 2030 goal for Scope 3 emissions
Adds details, graphic
15:22, 21 March 2023
US home sales surge; house prices post year-on-year drop
Existing home sales jump 14.5% in February
15:21, 21 March 2023
U.S. FDA to soon decide on second round of Omicron-tailored boosters - WSJ
Adds details from report
15:08, 21 March 2023People also watch
Still looking for a broker you can trust?
Join the 500.000+ traders worldwide that chose to trade with Capital.com